Living donor liver transplantation from a donor with definite obstetric antiphospholipid syndrome: a case report with perioperative risk mitigation strategy
Clinical Transplantation and Research · 2026-07-20
DOI: 10.4285/ctr.26.0031 ↗At a glance
Fallbericht in Clinical Transplantation and Research, published online on 2026-07-20. Written by Saurabh Jagdale and 7 co-authors. Institution: Department of Surgical Gastroenterology, GEM Hospital and Research Institute, Coimbatore, India.
Abstract (original language)
Aucun résumé disponible.
Subjects
Author keywords
Authors and institutions
- Department of Surgical Gastroenterology, GEM Hospital and Research Institute, Coimbatore, India.
- Department of Hepato-Pancreato-Biliary Surgery, GEM Hospital and Research Institute, Coimbatore, India.
ORCID profiles: Saurabh Jagdale, Anand Vijai N, Nalankilli V P, Abhay M Philip, Rajiv Maharaj, Naveen Kumar C, Dhinesh Kumar Nagarajan, Palanivelu C
Cite
APA
Jagdale, S., N, A. V., V P, N., Philip, A. M., Maharaj, R., C, N. K., Nagarajan, D. K., & C, P. (2026). Living donor liver transplantation from a donor with definite obstetric antiphospholipid syndrome: a case report with perioperative risk mitigation strategy. Clinical Transplantation and Research. https://doi.org/10.4285/ctr.26.0031
Vancouver
Jagdale S, N AV, V P N, Philip AM, Maharaj R, C NK, et al. Living donor liver transplantation from a donor with definite obstetric antiphospholipid syndrome: a case report with perioperative risk mitigation strategy. Clinical Transplantation and Research. 2026. doi:10.4285/ctr.26.0031
BibTeX
@article{Jagdale2026,
author = {Jagdale, Saurabh and N, Anand Vijai and V P, Nalankilli and Philip, Abhay M and Maharaj, Rajiv and C, Naveen Kumar and Nagarajan, Dhinesh Kumar and C, Palanivelu},
title = {Living donor liver transplantation from a donor with definite obstetric antiphospholipid syndrome: a case report with perioperative risk mitigation strategy},
journal = {Clinical Transplantation and Research},
year = {2026},
doi = {10.4285/ctr.26.0031}
}
EUVIMED